University of Miami Sylvester Comprehensive Cancer Center

 

University of Miami's 2nd Biennial Miami Leukemia Symposium
T

2020 Update on Splicing in MDS: How Can We Target Spliceosome-Mutant MDS?

By University of Miami's 2nd Biennial Miami Leukemia Symposium FEATURING Timothy Graubert
By University of Miami's 2nd Biennial Miami Leukemia Symposium FEATURING Timothy Graubert
0 views
October 23, 2020
Comments 0
Login to view comments. Click here to Login

Featured Video

08:18
Insights from 2023 ASH Annual Meeting

Treatment Strategies for Hematocrit Control in PV

Feat. A. Zhou

Featured Video

24:08
Indy Hematology Review

Evaluation, Diagnosis, Prognostication, and Emerging Therapies for M…

Feat. A. Tefferi
MDS Biology and Treatment
25:42
University of Miami's 2nd Biennial Miami Leukemia Symposium

2020 Update on MDS Mutational Landscape: What Are the Most Common MD…

Feat. R. Bejar
20:06
University of Miami's 2nd Biennial Miami Leukemia Symposium

2020 Update on Splicing in MDS: How Can We Target Spliceosome-Mutant…

Feat. T. Graubert
22:02
University of Miami's 2nd Biennial Miami Leukemia Symposium

TGF Beta Pathway Inhibition in MDS: Luspatercept Significantly Decre…

Feat. A. Verma
12:19
University of Miami's 2nd Biennial Miami Leukemia Symposium

How to Calculate Risk in MDS Patients?

Feat. M. Sekeres
14:36
University of Miami's 2nd Biennial Miami Leukemia Symposium

Frontline Therapies in MDS: Leveling Lower-risk MDS

Feat. M. Sekeres
05:28
University of Miami's 2nd Biennial Miami Leukemia Symposium

Frontline Therapies in MDS: Hampering Higher-risk MDS

Feat. M. Sekeres
10:48
University of Miami's 2nd Biennial Miami Leukemia Symposium

Hypomethylating Agents as SoC in MDS/AML: Clearance of TP53 Mutation…

Feat. D. Sallman
08:13
University of Miami's 2nd Biennial Miami Leukemia Symposium

Discussion on the Data of Frontline Combination Therapy with APR-246…

Feat. D. Sallman
05:21
University of Miami's 2nd Biennial Miami Leukemia Symposium

Magrolimab (Formerly 5F9) is a First-in-class Macrophage Immune Chec…

Feat. D. Sallman
27:33
University of Miami's 2nd Biennial Miami Leukemia Symposium

Overcoming Adaptive Therapy Resistance in AML: IRAK Signalling (via …

Feat. D. Starczynowski